Dr. Mark Mishra, MD
Claim this profileUniversity of Maryland/Greenebaum Cancer Center
Studies Brain Tumor
Studies Glioblastoma
21 reported clinical trials
46 drugs studied
Area of expertise
1Brain Tumor
Stage IV
IDH positive
1p/19q positive
2Glioblastoma
Stage I
Stage II
MET negative
Affiliated Hospitals
Clinical Trials Mark Mishra, MD is currently running
LITT + Radiation Therapy
for Brain Tumor
The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with newly diagnosed gliomas.
Recruiting1 award N/A8 criteria
Hypofractionated Radiation Therapy
for Prostate Cancer
A phase I trial to determine the safety of delivering three sequentially shorter RT schedules (20, 16, and 12 fractions) of HypoFx pelvic nodal RT in combination with a HypoFx, simultaneous integrated boost (SIB) to the prostate that have been designed to incrementally increased the biological equivalent dose (BED) to prostate cancer, while maintaining a constant BED to normal tissue toxicity.
Recruiting1 award Phase 111 criteria
More about Mark Mishra, MD
Clinical Trial Related8 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Mark Mishra, MD has experience with
- Stereotactic Radiosurgery
- Temozolomide
- Radiation Therapy
- Proton Beam Radiation Therapy
- Ipilimumab
- Nivolumab
Breakdown of trials Mark Mishra, MD has run
Brain Tumor
Glioblastoma
Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Mishra, MD specialize in?
Mark Mishra, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are IDH positive.
Is Mark Mishra, MD currently recruiting for clinical trials?
Yes, Mark Mishra, MD is currently recruiting for 10 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Mark Mishra, MD has studied deeply?
Yes, Mark Mishra, MD has studied treatments such as Stereotactic Radiosurgery, Temozolomide, Radiation Therapy.
What is the best way to schedule an appointment with Mark Mishra, MD?
Apply for one of the trials that Mark Mishra, MD is conducting.
What is the office address of Mark Mishra, MD?
The office of Mark Mishra, MD is located at: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland/Greenebaum Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.